Long-Term Reoperation Rates Following Pancreatoduodenectomy for Pancreatic Adenocarcinoma
BackgroundShort-term outcomes after pancreatoduodenectomy (PD) are well-studied, but long-term reoperation rates and their indications remain poorly characterized.MethodsA single-center retrospective chart review was performed on patients who underwent PD for pancreatic adenocarcinoma between 1/2011 and 12/2021. Reoperations occurring >90 days after PD were dichotomized to being related or unrelated to the index PD or pancreatic adenocarcinoma. The Kaplan-Meier analysis estimated the incidence of long-term reoperation at 1 and 5 years postoperatively.ResultsSix-hundred twenty-eight patients were included. The 5-year incidence of any additional operation >90 days after PD was 30.0% (95% CI 23.2-36.2%), and the 5-year incidence of any long-term related reoperation was 21.2% (95% CI 15.0-26.8%). The most common indications for reoperations by 5-year incidence were cancer recurrence (12.8%, 95% CI 7.6-17.7%), incisional hernia (6.2%, 95% CI 2.6-9.7%), small bowel obstruction (1.3%, 95% CI 0.2-2.4%), and leak, fistula, or infection (1.0%, 95% CI 0.1-2.0%). Of the examined risk factors, only 90-day reoperation was found to be predictive of long-term related reoperations (<i>P</i> = 0.02). Additionally, the 5-year incidence of endoscopic or interventional radiology procedures was 20.2% (95% CI 14.5-25.4%). However, 40.9% (95% CI 33.6-47.3%) of patients required additional surgery or procedures of any kind between 90 days and 5 years after PD.DiscussionWithin 5 years of PD, one in three patients required additional surgery, and one in five had operations for related indications. Related reoperative indications included recurrence, hernia, PD-specific complications, and small bowel obstruction. However, the rates of each of these reoperations were relatively low.
Authors
- Patrick P. Starlinger (ORCID: https://orcid.org/0000-0002-4666-5337)
- Mark Joseph Truty (ORCID: https://orcid.org/0000-0003-3776-527X)
- Cornelius A. Thiels (ORCID: https://orcid.org/0000-0003-3654-8601)
- Kristine T. Hanson (ORCID: https://orcid.org/0000-0003-2643-7596)
- Rory L. Smoot (ORCID: https://orcid.org/0000-0001-8543-661X)
- Chi Zhang (ORCID: https://orcid.org/0000-0002-9297-0690)
- Lauren Lu (ORCID: https://orcid.org/0000-0001-7299-5746)
- Susanne G Warner
- Ahmer Sultan
- Michael L. Kendrick
Institutions
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
Publication Details
- Journal
- The American Surgeon
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1177/00031348241304021
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00